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Abstract
Fat mass is linked mechanistically to the cardiovascular system through leptin,
a 16 kDa protein produced primarily by adipocytes. In addition to increasing
blood pressure via hypothalamic-sympathetic pathways, leptin stimulates
monocyte migration, cytokine secretion, and other functions that contribute
to atherosclerotic plaque development. These functions are also characteristics
of CD16-positive monocytes that have been implicated in the clinical progres-
sion of atherosclerosis. This investigation sought to determine if leptin pro-
moted the development of such CD16-positive monocytes. Cells from 45
healthy men and women with age ranging from 20 to 59 years were analyzed.
Circulating numbers of CD14++16++ monocytes, which are primary producers
of TNFa, were positively related to plasma leptin concentrations (P < 0.0001),
with a stronger correlation in men (P < 0.05 for leptin 9 sex interaction). In
vitro, recombinant human leptin induced CD16 expression in a dose-related
manner (P = 0.02), with a stronger influence on monocytes from men
(P = 0.03 for leptin 9 sex interaction). There were no sex-related differences
in total leptin receptor expression on any monocyte subtypes, relative expres-
sion of long versus short isoforms of the receptor, or soluble leptin receptor
concentrations in the plasma. The number of circulating CD14+16++ mono-
cytes, which preferentially migrate into nascent plaques, was positively related
to systolic blood pressure (R = 0.56, P = 0.0008) and intima-media thickness
(R = 0.37, P = 0.03), and negatively related to carotid compliance
(R = 0.39, P = 0.02). These observations indicate that leptin promotes the
development of CD16-positive monocyte populations in a sex-specific manner
and that these subpopulations are associated with diminished vascular
function.
Introduction
Cardiovascular disease affects one-third of the United
States population, and obesity-related metabolic disorders
are considered to be major causes (Begg et al. 2006). One
mechanistic link between body fat mass and the cardio-
vascular system is leptin, a 16 kDa protein produced pri-
marily by adipocytes. Leptin was originally identified as a
regulator of food intake and energy expenditure (Correia
and Haynes 2004), but it also increases blood pressure
(Hall et al. 2010) and promotes the development of ath-
erosclerosis (Beltowski 2006).
The hypertensive action of leptin is mediated via recep-
tors in the arcuate nucleus and other regions of the hypo-
thalamus that activate pro-opiomelanocortin neurons and
subsequently upregulate the sympathetic nervous system
(do Carmo et al. 2011). The slowly developing increase in
blood pressure is thought to be due primarily to increased
renal sympathetic nerve activity and subsequent sodium
retention (Hall et al. 2010). Numerous human studies
have reported positive correlations between circulating
leptin concentrations and blood pressure after controlling
for body fat (Kennedy et al. 1997; Schorr et al. 1998; Suter
et al. 1998; Kazumi et al. 1999; Guagnano et al. 2003).
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Leptin receptors are also expressed on blood monocytes
(Zarkesh-Esfahani et al. 2001), and leptin promotes the
development of monocyte activities that can contribute to
the progression of atherosclerosis. These include enhanced
adhesion and migration through the extracellular matrix,
upregulated scavenger receptor expression, increased
uptake of oxidized low-density lipoprotein (LDL) (Kon-
stantinidis et al. 2008), and secretion of TNFa (Santos-
Alvarez et al. 1999; Zarkesh-Esfahani et al. 2001).
These functional changes suggest that leptin might
induce a shift in the monocytes from a CD16-negative to
a CD16-positive phenotype (Santos-Alvarez et al. 1999;
Zarkesh-Esfahani et al. 2001). Whereas all circulating
monocytes express CD14, which is the receptor for bacte-
rial lipopolysaccharide (LPS), only a small subpopulation
(10–15%) coexpresses CD16 (Passlick 1989), which is an
FccIII receptor that binds IgG complexed with modified
LDL (Kiener et al. 1995). These CD16-positive monocytes
were first described as a single subpopulation (Passlick
1989) that, compared with CD16-negative monocytes,
were smaller, had somewhat diminished expression of
CD14, contained fewer cytosolic granules, and exhibited a
lower rate of phagocytosis (Belge et al. 2002; Geissmann
et al. 2003). These cells express a different set of chemoki-
ne receptors and adhesion molecules, and therefore have
different homing characteristics and functional properties
than CD16-negative monocytes (Weber et al. 2000). They
also tend to crawl across the luminal surface of endothe-
lial cells in patterns independent of the direction of blood
flow in a “patrolling” behavior thought to facilitate rapid
extravasation upon encountering local tissue damage
(Auffray et al. 2007).
Based on this original classification scheme, CD16-posi-
tive monocytes were associated with cardiovascular dis-
ease. Patients with coronary artery disease exhibited
higher circulating numbers of CD16-positive monocytes
than healthy controls (Schlitt et al. 2004), and those in
the highest quartile for circulating CD16-positive mono-
cytes also had significantly higher serum TNFa concentra-
tions. Moreover, CD16-positive monocytes accumulate in
human atherosclerotic lesions (Hakkinen et al. 2000). In
vitro, antibodies to CD16 blocked the vascular inflamma-
tion caused by IgG-activated human macrophages (Boyle
et al. 2012).
More recent studies have shown that CD16-positive
monocytes can be further subdivided into CD14++16++
and CD14+16++ subpopulations that have different func-
tional properties. Whereas CD16-negative (CD14++)
monocytes were shown to be the primary producers of
IL-10 and reactive oxygen species (Cros et al. 2010),
monocytes that strongly express CD14 along with CD16
(CD14++16+ and CD14++16++) are the primary sources of
IL-1b and TNFa. Monocytes that strongly express CD16
but less CD14 (CD14+16++) exhibit the patrolling behav-
ior leading to extravasation (Cros et al. 2010).
The aim of the present study was to test the hypothesis
that leptin induces CD16 expression on monocytes, and
to determine if increased CD16 expression is related to
carotid intima-media thickness (IMT), compliance, and
blood pressure in generally healthy human subjects.
Methods
Subjects
The first phase of the study involved 34 subjects (median
age 24 years), including 13 men, 11 women with natural
menstrual cycles, and 10 women who were using oral con-
traceptives. Exclusion criteria included smoking, current
pregnancy or lactation, or a history of chronic diseases such
as diabetes, liver disease, cardiovascular disease or cancer,
or any use of prescription drugs in the past 3 months.
Subjects reported for a first visit to the laboratory
between 7:30 and 9:00 AM, having fasted for at least 8 h,
and refrained from vigorous physical activity the preced-
ing day. All women were tested in the follicular phase of
their menstrual cycles (or the placebo phase of oral con-
traceptive cycles). Information regarding general health
was collected via questionnaire and self-reported physical
activity was quantified using the Godin and Shephard
(1985) scale. This was followed by noninvasive vascular
testing and lastly, acquisition of a blood sample by veni-
puncture of the antecubital vein. On a second visit, usu-
ally separated from the first by less than 2 weeks, the
aerobic capacity and body composition of the subjects
were determined.
In the second (follow-up) phase designed to determine
the causal influence of leptin on monocyte expression of
CD16, blood samples from an additional six men and five
women (four on oral contraceptives, median age
25 years) were collected for mononuclear cell isolation
and incubation with recombinant leptin in vitro. The
women were tested in the follicular or placebo phases of
their cycles. All procedures were approved by the Human
Assurance Committee (the Investigation Review Board) at
the Georgia Regents University, and all subjects provided
written informed consent.
Blood analyses
Blood collection and leukocyte isolation
Blood was collected into a 7 mL untreated tube for serum
and a 6 mL EDTA-treated tube for plasma. The serum
and plasma were aliquoted and frozen at 70°C for later
analysis. In addition, three 10 mL sodium heparin-treated
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tubes were drawn and the mononuclear cells were isolated
by density gradient centrifugation for cell culture.
In vitro cytokine secretion
Mononuclear cells were isolated by density gradient centri-
fugation using Ficoll-Hypaque (Sigma, St. Louis, MO), and
resuspended in RPMI-1640 medium (free of phenol-red
to avoid estrogen-like influences) supplemented with
2 mmol/L of L-glutamine, 100 U/mL penicillin, 100 lg/mL
streptomycin, 25 mmol/L Hepes buffer (all from Media-
tech, Manassas, VA), and 1% heat-inactivated autologous
plasma. Cells were then distributed in 24-well polystyrene
plates (Corning Glass Works, Corning, NY) at 2.5 9 106
cells/well and incubated with 0, 50, or 100 ng/mL of
recombinant human leptin (Cat # 398-LP, R&D Systems,
Minneapolis, MN, <1 endotoxin unit/lg protein) for 18 h
at 37°C in a humidified 5% CO2 atmosphere. After incuba-
tion, cell supernatants were collected and centrifuged at
12,000 g for 1 min to remove any aspirated cells, then ali-
quoted and frozen at 70°C for later cytokine analysis.
Cytokine analyses
Plasma and supernatant concentrations of IL-1b, TNFa,
IL-6, and serum concentrations of leptin were measured
using a cytometric bead array multiplex methodology
(CBA, BD Biosciences, San Jose, CA) and analyzed with a
BD FACSArray. The assays had detection limits (based on
95% confidence intervals over blank) of <5 pg/mL. The
intra-assay coefficients of variability (COVs) were between
4% and 10%; the interassay COVs were between 4% and
15%. Serum soluble leptin receptor concentrations were
determined with an ELISA kit from R&D Systems. The
detection limit was 0.06 ng/mL, inter- and intra-assay
COVs were 8.6% and 6.1%, respectively.
Hormone assays
Serum estradiol, progesterone, testosterone, and cortisol
concentrations were measured with ELISA kits from Bio-
Quant (San Diego, CA) with intra-assay COVs between
6% and 9%, and interassay COVs between 9% and 15%.
Plasma insulin and serum oxidized LDL concentrations
were determined with ELISA kits from ALPCO (Salem,
NH). The intra-assay COVs were 3–10% and the interas-
say COVs were 7–17%.
Glucose and lipoprotein assays
Serum glucose, triglyceride, total cholesterol, and high-
density lipoprotein/cholesterol (HDL) concentrations were
measured in a CLIA-certified core laboratory on the GRU
campus using an automated procedure (Envoy 500; Vital
Diagnostics Inc., Lincoln, RI).
Flow cytometric analysis of cell surface proteins
After removal of plasma from centrifuged EDTA-treated
blood, cells were washed in PBS without Ca++ or Mg++,
then labeled with monoclonal antibodies directed against
CD14 (clone M5E2, PerCP-Cy 5.5 label), CD16 (clone
3G8, Alexa Fluor 647 label) (both from BD Biosciences,
San Jose, CA), and leptin receptor (clone 52263, phycoery-
thrin [PE]-label, R&D Systems). Two additional incuba-
tion conditions were set up with antibodies against CCR2
(clone 48607, PE label, R&D Systems) and CX3CR1 (clone
2A9-1, PE label, BioLegend, San Diego, CA) in place of
antileptin receptor. After 30 min, PharmLyse (BD Bio-
sciences) was added to each tube, and incubated in the
dark at room temperature for 20 min to lyse the red cells.
The remaining leukocytes were centrifuged, washed, trea-
ted with stabilizing fixative (BD Biosciences), filtered
through 35 lm mesh, and analyzed using a Becton Dick-
inson 2-laser, 4-detector FACSCalibur Flow Cytometer cal-
ibrated with Calibrite beads. For each sample, 5000 events
were counted in the monocyte gate identified by a dual
parameter plot of forward scatter versus side scatter. In the
later studies with the second cohort of subjects (in vitro
induction of CD16 by leptin), monocytes were gated by
CD86 versus side scatter (using anti-CD86 clone 2331
[FUN-1] from BD Bioscience). Multicolor flow cytometry
was performed with appropriate one-color controls for
setting compensation for spectral overlap. Isotype controls
were run to test for nonspecific binding. Figure 1 illus-
trates how CD14/CD16 expression was categorized. Strict
rectilinear regions with vertical boundaries defined by the
bimodal distribution for CD14 in CD16-negative cells
(regions A and B), and horizontal boundaries defined by
the bimodal distribution of CD16 in CD14-negative cells
(regions A and F) were constructed for each dot plot.
Western blot analysis of leptin receptor isoforms
Cells were isolated from heparinized blood by density gra-
dient centrifugation as described previously, washed in
sterile saline, and then 106 cells were lysed in 200 lL of Lae-
mmli sample buffer (Bio-Rad, Hercules, CA) heated to
95°C for 5 min. Lysates were frozen at 70°C until ana-
lyzed. Samples were electrophoresed on a 4–20% TGX Cri-
terion gel (Bio-Rad) at 200 V constant voltage, then
transferred to a polyvinylidene difluoride (PVDF) mem-
brane at a constant voltage of 100 V. Membranes were
washed in PBS/Tween 20, blocked in 5% milk, then labeled
with monoclonal antileptin receptor (clone 52263, R&D
Systems), and a secondary anti-mouse IgG conjugated to
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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horseradish peroxidase (Jackson ImmunoResearch Labora-
tories, West Grove, PA). The labeled membrane was stained
using West Femto chemiluminescent substrate (Thermo-
Scientific, Rockford, IL), imaged using a ProteinSimple
FluorChem Imager (ProteinSimple, Santa Clara, CA), and
analyzed with AlphaView software (ProteinSimple).
Leptin-induced CD16 expression in vitro
In early experiments, cells were incubated in polypropyl-
ene tubes under the conditions described previously for
cytokine secretion, then analyzed for membrane expres-
sion of CD14 and CD16 by flow cytometry. These preli-
minary experiments yielded no evidence of an influence
by leptin and were discontinued due to resource/logistical
limitations. However, after an in vivo association between
serum leptin and native CD16 expression became evident,
blood samples from 11 additional subjects were collected
and their mononuclear cells were isolated and incubated
as in the earlier experiments, except higher concentrations
of leptin were used: 10 and 100 nmol/L (160 and
1600 ng/mL). After 18 h of incubation, the cells were
analyzed for membrane expression of CD14 and CD16 by
flow cytometry.
Vascular testing
All vascular measures were measured twice during a given
testing session and averaged.
Blood pressure
Seated and supine blood pressures were measured via
automatic oscillometry (Dinamap ProCare 100, General
Electric) in the left arm after at least 5 min of rest. Supine
brachial blood pressure was taken periodically during the
vascular testing procedures and was used to calculate car-
otid compliance.
Carotid arterial compliance
Arterial compliance of the carotid artery was determined
by the technique of ultrasound imaging with sequential
applanation tonometry. Briefly, the common carotid
artery diameter was measured from images derived from
an ultrasound machine (Envisor, Philips Medical, Bothel,
WA) equipped with a high-resolution, 7.5 MHz linear
probe (Cortez-Cooper et al. 2008). These ultrasound
images were transferred to a computer, digitized and
analyzed for maximal systolic expansion, and basal
(minimum) diastolic relaxation using semiautomated
edge-detection image analyzer software (Carotid artery
analyzer tool, Medical Imaging Applications, LLC, Coral-
ville, IA). All image analyses were performed by the same
investigator to eliminate intertester variability.
Common carotid blood pressure waveforms were
obtained from the ipsilateral artery with a pencil-type
probe incorporating a pressure transducer (SPT 301,
Millar Instruments, Houston, TX) and interfaced with a
computer (PowerLab, ADInstruments, Colorado Springs,
CO). Carotid systolic blood pressure was corrected for
hold down pressure as described by Armentano et al.
(1995). A minimum of 20 cardiac cycles were captured
for offline analysis.
Arterial compliance and carotid pulse pressure were
calculated as described previously Cortez-Cooper et al.
(2008). In our laboratory, the mean difference for
test–retest reliability for carotid pulse pressure is
Figure 1. Two representative examples of CD14 and CD16 expression on monocytes (after forward-/side-scatter gating). CD14++ monocytes
are contained in region B, CD14++16+ monocytes are in region C, CD14++16++ monocytes are in region D, and CD14+16++ monocytes are in
region E. Region A contains cells that express neither CD14 nor CD16; region F contains cells that are CD16-positive but CD14-negative.
Regions A and F were used for defining the other regions, as described in the Methods section.
2014 | Vol. 2 | Iss. 10 | e12177
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1.5  1.6 mmHg and the ICC1,1 is 0.85. For carotid end-
diastolic diameter, ICC1,1 is 0.93 with a mean difference
of 0.21  0.12 mm.
Carotid IMT
Carotid IMT was measured from the ultrasound images
recorded during compliance measurements. IMT was
measured at end-diastole with the lumen-intima and
media-adventitia boundaries traced automatically and cal-
culated as the average of 0.1 mm samples over 10 mm
using specialized software (carotid artery analyzer tool,
Medical Imaging Applications, LLC, Coralville, IA).
Aerobic capacity testing
Aerobic fitness can influence vascular function, therefore
we measured aerobic capacity (VO2peak) by open-circuit
spirometry (Sensormedics Vmax Spectra, Yorba Linda,
CA) during an incremental cycle ergometer exercise pro-
tocol. The cycling rate was held constant at 70 rpm and
the resistance was increased 25 W every 2 min after an
initial 3-min warm-up at 25 W. A 12-lead ECG was mon-
itored continuously, and blood pressure (conventional
sphygmomanometry) and ratings of perceived exertion
(Borg RPE scale) were recorded at the end of each stage.
Exercise continued until subject exhaustion and an RPE
of ≥17. All exercise testing was supervised by a cardiolo-
gist. Results reported in this manuscript are expressed as
milliliters of oxygen consumed per minute per kilogram
of fat-free mass (mL O2/min/kg ffm).
Body composition
Fat-free soft tissue and percent body fat were determined
by dual energy X-ray absorptiometry whole body scan
(Hologic Discovery W Densitometer, Hologic Inc., Bed-
ford, MA). Each scan was compartmentalized and ana-
lyzed using Hologic software.
Data analysis
All statistical analyses were performed using Statview sta-
tistical software (SAS, Cary, NC). Circulating CD16-posi-
tive monocyte counts were normalized by square root
transformation, whereas serum leptin and oxidized LDL
concentrations were normalized by log transformation.
Results are reported by mean  SEM, unless specifically
stated otherwise. Differences in surface antigen expression
on monocyte subpopulations were assessed by analysis of
variance, using the Bonferroni/Dunn test for multiple
pairwise post hoc comparisons. Leptin-induced CD16
expression was assessed by two-factor (leptin dose 9 sex)
repeated measures ANOVA. Correlations between vari-
ables were analyzed by simple regression, multiple regres-
sion, or analysis of covariance, as stipulated in the text.
Stepwise multiple regression analyses were performed
using an F-to-enter of 4.0 and standardized regression
coefficients (b) are reported for independent factors.
A P-value <0.05 was considered statistically significant.
Results
Subject characteristics
The characteristics of the first cohort of research subjects
are presented in Table 1. The men were significantly taller
and heavier, whereas the women had significantly higher
body fat percentages, serum leptin, and HDL concentra-
tions. Seven women and six men were classified as prehy-
pertensive, with casual systolic blood pressures
≥120 mmHg. No significant sex-related differences were
found for age, aerobic capacity (normalized to fat-free
mass), physical activity levels, blood pressure, blood glu-
cose, or other cholesterol concentrations. Serum leptin
concentrations correlated positively with % body fat
(R = 0.91, P < 0.0001).
Circulating monocyte subpopulations
Two distinct patterns of CD14++ monocyte subpopula-
tions were observed among the subjects: either the major-
ity of CD14++ cells were CD16-negative (Fig. 1A) or else
expressed low levels of CD16 (CD14++16+, Fig. 1B).
Together, these two subpopulations accounted for 81.4%
of total monocytes, whereas 6.3% were CD14++16++ and
5.7% were CD14+16++. Overall, circulating monocyte
counts were higher in men than in women (P = 0.02),
although within specific subpopulations the difference
was statistically significant only for the CD14++16++ cells
(P = 0.001, Fig. 2).
The CD14++ and CD14++16+ cells were similar in
terms of chemokine receptor expression (Fig. 3) and dif-
fered greatly from the CD14++16++ cells, which expressed
less than half as much CCR2 and over twice as much
CX3CR1. The CD14+16++ monocytes expressed essentially
no CCR2, whereas CX3CR1 levels were similar to the
CD14++16++ cells.
Leptin and CD16 expression
The number of circulating CD16-positive monocytes was
related in a sex-specific manner to serum leptin concen-
tration, with the strongest association exhibited by the
CD14++16++ cells (Fig. 4). The P-values for leptin correla-
tions with CD14++16+ cells and CD14+16++ cells were
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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0.06 and 0.01, respectively. The CD16-negative (CD14++)
cells exhibited no association with serum leptin
(P = 0.51). Age, body fat, sex hormone concentrations,
glucose, and serum lipids were not retained as significant
factors when included along with leptin in stepwise multi-
ple regressions for any of the monocyte subpopulations.
Aerobic capacity was identified as a significant factor for
the CD14+16++ subpopulation only (Fig. 5).
Leptin induced sex-specific increases in CD16 expres-
sion in isolated mononuclear cells incubated in vitro with
10 and 100 nmol/L doses of human recombinant leptin.
The results are illustrated in Figure 6. A statistically signifi-
cant main effect of leptin was observed for the CD14++16+
monocytes (P = 0.02), and significant leptin 9 sex interac-
tions were observed for the CD14++16++ and CD14+16++
subpopulations (P = 0.03).
Leptin receptor expression
Leptin receptor expression quantified by flow cytometry
was highest on CD14++ and CD14++16+ monocytes, inter-
mediate on CD14++16++ monocytes, and lowest on
CD14+16++ cells (Fig. 7). No sex-related differences in
expression were detected. Western blots revealed two dis-
tinct bands at approximately 150 and 100 kDa (Fig. 8),
corresponding to the long and short isoforms of the lep-
tin receptor reported previously for human macrophages
(Hongo et al. 2008). No sex-related differences were
detected in the relative expression (ratio) of the long/
short isoforms quantified by densitometry (Fig. 8), or in
circulating concentrations of soluble leptin receptors
(Table 1).
Leptin receptor expression was inversely related to aer-
obic capacity for the CD14++ subpopulation (R = 0.42,
P = 0.01, Fig. 9) and the CD14++16+ subpopulation
Figure 2. Circulating monocyte counts (n = 34). Black bars
represent men, gray bars represent women. *The CD14++16++
monocyte count was significantly higher in men than women,
P = 0.001.
Table 1. Physical characteristics and blood analyses of the research subjects.
Men (n = 13) Women (n = 21) P-value
Age (years) 26.6 (21–36)1 26.1 (21–40)1 –
Height (meters) 1.76  0.02 1.63  0.01 <0.0001
Weight (kg) 81.8  3.8 67.1  2.4 0.002
Body fat (%) 19.9  1.7 30.5  1.4 <0.0001
Godin score 39.6  7.4 35.0  5.6 –
VO2max (mL/min/total kg) 34.2  3.1 28.2  1.6 0.064
VO2max (mL/min/fat-free kg) 45.6  3.4 43.9  1.8 –
Systolic BP (mmHg) 118  3 113  2 –
Diastolic BP (mmHg) 76  3 72  2 –
Glucose (mg/dL) 88.1  1.5 85.7  1.6 –
Insulin (lIU/mL) 6.02  1.11 7.30  0.98 –
Cortisol (ng/mL) 128  29 96  8 –
Total cholesterol (mg/dL) 169  8 162  6 –
HDL (mg/dL) 42.2  2.7 53.1  2.0 0.003
LDL (mg/dL) 105  7 89  7 –
Oxidized LDL (ng/mL) 235 (763)2 197 (1735)2 –
Triglycerides (mg/dL) 91.3  11.2 70.1  5.7 0.08
Leptin (ng/mL) 4.60 (8.82)2 9.79 (9.05)2 0.001
Soluble leptin receptor (ng/mL) 25.9  1.7 30.1  2.6 –
All values are mean  standard error, except as indicated. –: Not statistically significant.
1Mean (range).
2Median (interquartile range).
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(R = 0.35, P = 0.04, not shown), but not the
CD14++16++ or CD14+16++ subpopulations. Age, body
fat, aerobic capacity, and traditional cardiovascular risk
factors (glucose, lipids) were not retained as significant
factors when included in stepwise multiple regressions.
Leptin-induced cytokine secretion
Overall, recombinant human leptin induced secretion of
TNFa secretion in a dose-related manner, from baseline
levels of 49  11 pg/mL, to 54  12 pg/mL at a dose of
50 ng/mL leptin, and 61  12 pg/mL at 100 ng/mL lep-
tin (P < 0.0001). Nevertheless, individual responses varied
considerably, with cells from a few subjects even exhibit-
ing slight decreases in TNFa secretion in response to
leptin. The variations in response (quantified as areas
under the dose response curve) were not related to sex, but
did correlate with the summed percentages of CD14++16+
and CD14++16++ in the cell cultures (R = 0.44, P = 0.01,
Fig. 10). No significant leptin-induced changes in IL-1b or
IL-6 secretion were observed at 50 or 100 ng/mL, however,
with the higher doses used with the second cohort of sub-
jects (10 nmol/L [160 ng/mL] or 100 nmol/L [1600 ng/
mL]), significant dose-related increases in IL-1b and IL-6
were observed (Fig. 11).
CD14+16++ monocytes and cardiovascular
parameters
Significant correlations were observed between circulating
14+16++ monocyte counts and carotid systolic blood pres-
sure (R = 0.56, P = 0.0008, Fig. 12), carotid IMT
(R = 0.37, P = 0.03, Fig. 13), and carotid compliance
A B
Figure 3. Receptor expression on circulating monocyte subpopulations expressed as mean fluorescence intensity minus fluorescence of the
isotype control (n = 34). (A) CCR2: a > b > c, all pairwise comparisons P < 0.0001. (B) CX3CR1: a < b, P < 0.0001.
Figure 4. Circulating CD14++16++ monocytes correlate with serum
leptin concentrations (P < 0.0001) in a sex-specific manner
(leptin 9 sex interaction P < 0.05). Mean CD14++16++ counts were
significantly higher for men than women (P < 0.0001), and
exhibited a stronger correlation with serum leptin (R = 0.80,
P = 0.0009) than for women (R = 0.60, P = 0.005).
Figure 5. Circulating CD14+16++ cells plotted as a function of the
cell donor’s aerobic capacity (R = 0.41, P = 0.02).
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(R = 0.39, P = 0.02, Fig. 14). Age, sex, sex hormones,
body fat, and traditional cardiovascular risk factors were
not retained as significant factors when included in step-
wise multiple regressions.
Discussion
This study provides in vivo (Fig. 4) and in vitro
(Fig. 6) evidence that leptin promotes CD16 expression
on human monocytes. Furthermore, the present study
provides data consistent with previous clinical data
(described in the introduction) that CD16-positive
monocytes are associated with diminished vascular func-
tion (Figs. 12–14). Thus, on a systemic level, leptin
may be a critical link between increased adiposity and
vascular disease. The percent body fat in our study
population ranged from 10.8% to 43.3%, yet neither
body fat nor serum lipoprotein concentrations were sig-
nificant factors in the multiple regression analyses. This
suggests that leptin itself, rather than adiposity or other
related factor, is the key element.
This study did not address how leptin may affect CD16
expression on a cellular level. However, it is known that
leptin can induce the transcription factors PU.1 (Jaedicke
et al. 2013), AP-1 (Maingrette and Renier 2003), and
NFjB (Haugen and Drevon 2007), and that the CD16
promoter has response elements for these transcription
factors (Gessner et al. 1995), so a direct effect on CD16
transcription is a possibility.
Figure 6. Leptin-induced expression of CD16 on CD86+ monocytes
in vitro. The three panels show the percentages of each cell type
after 18 h of incubation in vitro with 0, 0.16, or 1.6 lg/mL leptin.
The solid black symbols represent cells from men (n = 6) and the
open gray symbols represent cells from women (n = 5). A
significant main effect by leptin was observed for CD14++CD16+
monocytes (bottom panel, P = 0.02), and significant leptin 9 sex
interactions were observed for CD14++CD16++ and CD14+CD16++
cell populations (middle and top panels, both P = 0.03). In the men
only, leptin-induced increases were statistically significant for the
CD14++16+ (P = 0.0002) and CD14++16++ (P = 0.004) populations.
Figure 7. Native leptin receptor expression on monocytes. Data for
each monocyte subtype are expressed as median fluorescence
intensity minus isotype control fluorescence. (n = 34). Statistical
key: a > b > c, all pairwise comparisons P < 0.002.
Figure 8. Left: Western blot results for three subjects showing
relative expression of long leptin receptor isoform (150 kDa) and
short isoforms (100 kDa). Right: Densitometric measurements are
presented as the ratio of long/short isoforms, for men versus
women. No statistically significant sex difference was observed.
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The present observation that high concentrations of
leptin increase CD16 expression on monocytes isolated
from the peripheral circulation is consistent with previous
gene profiling studies (Ancuta et al. 2009; Wong et al.
2011) and adoptive-transfer experiments (Yrlid et al.
2006) in supporting a “linear differentiation model.” In
this model, monocytes are released from the bone mar-
row as CD14++/CD16-negative cells, then progress
through intermediate stages characterized by strong
expression of both CD14 and CD16, and subsequently
mature to an advanced stage with diminished expression
of CD14. However, the present data do not exclude the
alternate possibility that some CD16-positive monocytes
might also originate independently from separate bone
marrow precursor cells (Hanna et al. 2011), and this
might be the stage that physiological concentrations of
leptin have the greatest effect.
Many previous reports have grouped CD14++ and
CD14++16+ cells (regions B and C in Fig. 1) together as a
single “CD16-negative” population. As shown in Figure 3,
these cells do exhibit similar expression of chemokine
receptors. However, in the present study, it was important
to differentiate between these regions in order to investi-
gate the influence of leptin on CD16 expression. In fact,
in vitro treatment with recombinant leptin produced the
greatest increase in region C (CD14++16+ cells). Thus, dif-
ferences in endogenous leptin concentrations may explain
the variations in circulating CD14++16+ cells observed
among individuals (Fig. 1A vs. B). Moreover, the percent-
age of CD14++16+ cells in culture (along with
CD14++16++ cells) correlated with TNFa secretion in
vitro (Fig. 10). This latter observation is in accordance
with the data reported by Cros et al. (2010), who defined
a “CD14+16+” monocyte subpopulation that corresponded
to regions C and D in Figure 1. These CD14+16+ were the
primary producers of IL-1b and TNFa.
Sex-related differences
In our study, circulating CD14++16++ monocyte counts
were higher – and the association with serum leptin was
more pronounced – in men than in women. Likewise,
recombinant leptin induced CD16 expression on cells iso-
lated from men, but not women. These differences could
not be explained by any sex-related differences in total
leptin receptor expression on the monocytes, assessed by
flow cytometry. However, flow cytometry only detects the
extracellular domains of the leptin receptors and does not
differentiate between the long form of the receptor (which
has a more extensive cytosolic domain) and several
shorter forms with less cytosolic structure and fewer sig-
naling capabilities (Bjorbaek et al. 1997). Western blots
were performed to differentiate between receptor iso-
forms, but no significant sex-related difference in the rela-
tive expression of the long versus short forms was
observed. These results are in accordance with two previ-
ous studies that found no sex-related differences in
mRNA transcripts for the receptor isoforms in peripheral
blood mononuclear cells (Tsiotra et al. 2000; Stefanou
et al. 2005). Nevertheless, the sex-related differences in
CD16 expression observed in the present study are consis-
tent with previous reports that women have lower
circulating CD16-positive monocyte counts than men
(Heimbeck et al. 2010). Kramer et al. (2004) reported
that estradiol inhibited CD16 expression on monocytes in
vitro, via mechanisms involving both a and b forms of
the estrogen receptor (Kramer et al. 2007). In our study,
Figure 9. Leptin receptor expression on CD14++ monocytes plotted
as a function of aerobic capacity (R = 0.42, P = 0.01).
Figure 10. Leptin-induced TNFa secretion (expressed as area under
curve) plotted as function of the percentage of CD14++16+ and
CD14++16++ monocytes in the blood sample (R = 0.44, P = 0.01).
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neither total number of circulating monocytes nor mono-
cyte subpopulations were related to testosterone, estradiol,
progesterone, luteinizing hormone, or follicle-stimulating
hormone concentrations.
Soluble leptin receptor concentrations
The biological activity of leptin can be influenced by solu-
ble leptin receptors that are shed from cell membranes
and circulate in the bloodstream (Maamra et al. 2001). At
low ratios of circulating soluble leptin receptor-to-leptin,
the soluble receptors may act as chaperones that extend
leptin’s biological half-life, and when present in molar
excess (>2/1) they inhibit leptin activity (Huang et al.
2001; Zastrow et al. 2003). In the present study, the med-
ian molar ratio was low: 0.74 (interquartile range, 0.86).
Serum soluble leptin receptor concentrations were not
related to sex, leptin receptor expression on the total
monocyte population or to receptor expression on any of
the monocyte subpopulations. None of the monocyte- or
vascular-related variables measured in this study were
associated with soluble leptin receptor concentrations or
with soluble receptor/leptin ratios.
Physical activity and leptin receptor
expression
Expression of leptin receptors on CD14++ and CD14++16+
monocytes was negatively correlated with aerobic capacity
(Fig. 9). A similar negative influence of physical activity
A B
Figure 11. Leptin-induced increases in IL-1b, IL-6 (light gray bars), and TNFa (dark gray bars) in vitro. (A) Responses to physiological doses of
leptin by mononuclear cells isolated from the first cohort of subjects (n = 34, *P < 0.0001 by repeated measures ANOVA). (B) Responses to
supraphysiological doses of leptin by mononuclear cells isolated from the second cohort of subjects (n = 11, †P = 0.003, ‡P = 0.025 by
repeated measures ANOVA).
Figure 12. Carotid systolic blood pressure plotted as a function of
the number of circulating CD14+16++ cells (R = 0.58, P = 0.0008).
Figure 13. Carotid intima-media thickness plotted as a function of
the number of circulating CD14+16++ cells (R = 0.37, P = 0.03).
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has been observed on leptin receptor expression in other
tissues. Hypothalamic tissue from rats given access to
exercise wheels for 12 weeks exhibited lower leptin recep-
tor gene expression than tissue from sedentary controls
(Kimura et al. 2004). Likewise, leptin receptor gene
expression was reduced in the livers of treadmill-trained
rats (Yasari et al. 2009), and in the subcutaneous fat of
rats given access to exercise wheels (Pardo et al. 2010).
However, physical activity has the opposite influence on
leptin receptor expression in skeletal muscle: Wheel
running increased leptin receptor protein expression in
gastrocnemius and soleus muscles of rats (Pardo et al.
2010), and increased leptin receptor protein was detected
in hypertrophied triceps muscles of humans (Olmedillas
et al. 2010). The authors suggested that this upregulation
represents a local adaptation in leptin signaling that may
contribute to training-induced increases in skeletal muscle
fatty acid oxidation.
CD14+16++ monocytes and vascular function
In the present study, blood pressure and carotid IMT cor-
related positively with the number of circulating
CD14+16++. These data are consistent with previous
reports that CD14+16++ monocyte counts correlate with
IMT in healthy adults (Rogacev et al. 2010), and with
blood pressure in patients with coronary artery disease
(Hristov et al. 2010). Prospective studies of patients with
chronic kidney disease indicated that elevated
CD14++16++ monocyte counts were associated with
higher rates of cardiovascular events in nondialysis
patients (Rogacev et al. 2011), and associated with higher
rates of both cardiovascular events and fatalities in
patients who were on dialysis (Heine et al. 2008).
In the present study, the number of CD14+16++ mono-
cytes was inversely related to aerobic capacity (Fig. 5).
Timmerman et al. (2008) first demonstrated that physi-
cally active seniors (65–80 years of age) had lower per-
centages of circulating CD16-positive monocytes than
sedentary seniors . These authors suggested that exercise-
induced glucocorticoids may cause the effect because
methylprednisone therapy reduced CD16-positive mono-
cyte counts in patients with multiple sclerosis (Fingerle-
Rowson et al. 1998) and in healthy volunteers (Steppich
et al. 2000). We did not collect mid- or postexercise
blood samples to test this possibility, but no significant
correlations were observed between resting serum cortisol
concentrations and CD14+16++ monocyte counts. An
alternative explanation may be provided by observations
that acute exercise causes an immediate increase in
CD16-positive monocyte counts (Steppich et al. 2000),
but within an hour of recovery, these counts drop to less
than half of pre-exercise baseline (Simpson et al. 2009).
Perhaps regular exercise repeatedly mobilizes marginated
CD16-positive monocytes into the circulation and then
they extravasate into muscle and other peripheral tissues
that experience low-level inflammation as a result of the
stress of exercise (Cannon et al. 1989), resulting in lower
steady-state numbers in the vascular compartment at rest.
The results of the present study suggest a third possibility:
Physical activity reduces leptin receptor expression on
CD14++ monocytes rendering them less susceptible to
leptin-induced CD16 expression.
Limitations
We began testing the first cohort of subjects before Heim-
beck et al. (2010) and Zawada et al. (2012) published
important papers illustrating the value of gating the total
monocyte population using a pan-monocyte marker such
as CD86 or HLA-DR, rather than the traditional method
of forward-/side-scatter characteristics. Selecting cells by
scatter characteristics alone can increase the risk of
including CD16-positive neutrophils or NK cells in
CD14+16++ monocyte subpopulation (region E in Fig. 1).
The second cohort of subjects provided an opportunity to
compare our whole-blood flow cytometry measurements
based on forward-/side-scatter gating with CD86 gating.
No significant difference in the absolute number of cells
measured in region E of Figure 1 was observed, but
CD86 gating did eliminate of most of the cells in regions
A and F. As a result, enumeration of each monocyte sub-
population as a percentage of total monocytes was under-
estimated when forward-/side-scatter gating was used,
compared to CD86 gating. Nevertheless, percentages cal-
culated from the results of each gating method were
strongly correlated (e.g., R = 0.94, P = 0.0002 for the
Figure 14. Carotid compliance plotted as a function of the
number of circulating CD14+16++ cells (R = 0.39, P = 0.02).
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 10 | e12177
Page 11
J. G. Cannon et al. Leptin Regulates Monocyte CD16 Expression
CD14+16++ subpopulation). Therefore, the relative differ-
ences in monocyte subpopulations reported here with
respect to sex, leptin, and aerobic capacity would be simi-
lar with either gating method.
The effective doses of recombinant leptin required to
significantly increase CD16 expression in vitro were
higher than the physiological range. This may have been
due to an inability to accurately reproduce in vivo condi-
tions in the primary cell cultures. Perhaps endogenous
hormone or cytokine cofactors were absent. Alternatively,
the timing of leptin administration with respect to mono-
cyte development and/or the duration of incubation may
not have been optimal.
Peripheral blood mononuclear cells were analyzed by
western blots for differentiation of long and short iso-
forms of the leptin receptor. Although monocytes express
higher levels of leptin receptors than lymphocytes (Zar-
kesh-Esfahani et al. 2001), lymphocytes comprise the
majority of cells isolated by density gradient centrifuga-
tion. If a sex difference in leptin receptor expression was
limited to the monocytes or a subpopulation of mono-
cytes, the difference might have been missed due to the
presence of lymphocytes.
Summary
Increased numbers of circulating monocytes expressing
CD16 have been associated clinically with increased risk
of cardiovascular disease. The present study has shown
that expression of CD16 on monocytes correlated with
serum leptin concentrations in vivo, and that CD16
expression on monocytes can be induced with recombi-
nant leptin in vitro in a sex-specific manner. In addition,
circulating CD14+16++ monocyte counts were negatively
related to carotid compliance, and positively related to
blood pressure and carotid IMT. Finally, leptin receptor
expression on CD14++ and CD14++16+ monocytes was
negatively correlated with aerobic capacity. Taken
together, these observations support the general concept
that fatness promotes cardiovascular dysfunction, in part,
by leptin-induced changes in monocyte phenotype, and
that fitness opposes this effect by reducing leptin receptor
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